Biotech

TomoTherapy has filed with the Securities and Exchange Commission for an initial public offering that would raise up to $201 million in capital. The Madison-based medical device manufacturer has applied for a listing on the NASDAQ Global Market. ...

A manufacturing partner that has helped large and mid-size manufacturers become more lean and mean is now setting its sights on smaller manufacturers that need help implementing growth strategies. Among the possible beneficiaries are information technology, biotechnology, and medical device businesses. ...

Laura Strong has been appointed president and chief operating officer of the Madison biopharmaceutical firm Quintessence Biosciences. She has served as vice president of the company since the year 2000. ...

Two Wisconsin firms have filled key executive positions with the same man, biotechnology executive Gregg Fergus. Fergus will join Baird Venture Partners and one of its portfolio companies, Caden Biosciences, which was relocated to Madison as part of $5.8 venture financing deal led by Baird. ...

As is the case with most major reform efforts, it looks as though healthcare reform will be led by the states, writes Inside Wisconsin columnist Tom Still. Gov. Jim Doyle has urged the Legislature to work with him to expand access and lower costs, and...

Governor Jim Doyle has unveiled a package of economic initiatives called Grow Milwaukee that includes several technology and biotechnology spending initiatives. Chief among them is an $8 million funding commitment for the University of Wisconsin-Milwaukee's Research Growth Initiative, but the overall package has one lawmaker...

Western Wisconsin is no longer just for farmers and tourists - it is going high tech. As Inside Wisconsin columnist Tom Still explains, the spill over from the Twin Cities explains some of the growth, but a commitment to regional cooperation, which should be adopted...

Wisconsin would like to lure a Georgia biotechnology company involved in stem cell research, but that may turn out to be easier said than done. The University of Georgia is trying to beat officials and investors here to the punch and give Aruna Biomedical...